LRG1,一种用于IMCD疾病活动的新型血清生物标志物
Miao-Yan Zhang1, Zi-Han Yang1, Yu-Chong Qiu1
1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 ShuaifuyuanNo. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Biomarker research
|April 8, 2025
概括
富含白的α-2-甘氨蛋白-1 (LRG1) 显示出作为异常多中心卡斯特曼病 (iMCD) 的生物标志物具有前途. 较低的LRG1水平表明iMCD患者的治疗反应是积极的.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 异常多中心卡斯特曼病 (iMCD) 是一种罕见的淋巴增殖性疾病,具有系统性炎症和多器官功能障碍.
- 目前对IMCD的治疗反应评估由于临床异质性而缺乏敏感性.
- 细胞因子风暴驱动iMCD的病变发生.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.6K
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
15.8K
